Cargando…
Editorial: Resistance to Medical Therapy in Pituitary Tumors
Autores principales: | Auriemma, Renata S., Gahete, Manuel D., Gatto, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905516/ https://www.ncbi.nlm.nih.gov/pubmed/35282458 http://dx.doi.org/10.3389/fendo.2022.861230 |
Ejemplares similares
-
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
por: Pivonello, Claudia, et al.
Publicado: (2022) -
Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019) -
Editorial: Systems Biological Aspects of Pituitary Tumors
por: Zhan, Xianquan, et al.
Publicado: (2016) -
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Pirchio, Rosa, et al.
Publicado: (2021) -
Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas
por: Auriemma, Renata S., et al.
Publicado: (2019)